SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: billkirn who wrote (2679)11/7/1997 9:18:00 AM
From: JOHN W.  Respond to of 6136
 
Subject: Re: Oct scrips
Date: Fri, Nov 7, 1997 02:52 EST
From: LMoss
Message-id: <19971107075201.CAA28259@ladder02.news.aol.com>

New prescriptions for October were reported as follows:

Week ending New scrips

Oct. 3 2960
Oct. 10 3213
Oct. 17 3028
Oct. 24 3047

The number of new scrips appears to be stable at around 3000/wk. Note that this is long after analyst's predictions of a peaking six to eight weeks after launch in March.

LMoss




To: billkirn who wrote (2679)11/7/1997 9:54:00 AM
From: JOHN W.  Respond to of 6136
 
Today is a retest of the entire mkt. Iraq, Asia, and Employment report was just the catalyst for this preordained retest today.

I plan to buy more AGPH today as the mkt drags it down.